Maria Sitarou
Larnaca, 6301, Cyprus
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients.
Journal: International journal of molecular sciences
Published: July 31, 2025
Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference.
Journal: Cells
Published: October 15, 2023
Context base editing for splice correction of IVSI-110 β-thalassemia.
Journal: Molecular therapy. Nucleic acids
Published: October 04, 2023
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis.
Journal: Frontiers in genome editing
Published: January 10, 2023
Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells.
Journal: International journal of molecular sciences
Published: February 15, 2021
Sex-specific transcriptional profiles identified in β-thalassemia patients.
Journal: Haematologica
Published: August 21, 2020
Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBBIVSI-110 (G > A) β-Thalassemia.
Journal: International journal of molecular sciences
Published: July 18, 2020
Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures.
Journal: Journal of clinical medicine
Published: November 13, 2019
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements.
Journal: Journal of clinical medicine
Published: September 27, 2019
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
Journal: Haematologica
Published: April 21, 2019
Last Updated: 09/26/2026